Introduction: Birth weight has historically been used as an indicator to assess fetal growth, and newborns below the 10th percentile for a given gestational age have generally been associated with poor outcomes. Current knowledge about the functional capacity of the immune system in the first weeks of life highlights the importance of infections as one of the most important causes of morbidity and mortality in newborns. Objective: To identify risk factors for the onset of immunodeficiency in births with restriction of the fetal growth at the Mariana Grajales Gynecological-Obstetric Hospital in the municipality of Santa Clara, Villa Clara province, from January 2016 to December 2023. Material and Methods: A descriptive, cross-sectional, and retrospective study was carried out in births with restriction of the fetal growth at the Gynecological-Obstetric Hospital of the municipality of Santa Clara, Villa Clara province, from January 2016 to December 2023. The universe was made up of 44 patients. Results: The main risk factor was a history of admission, which represented 56% of the total, followed by not breastfeeding, which in turn represented 40% of the total cases analyzed. Conclusions: It is important to understand the risk factors for the development of immunodeficiency, as well as the warning signs, in order to understand the mechanism of its onset and prevent conditions from leading to the underlying cause.
Published in | Science Journal of Clinical Medicine (Volume 14, Issue 3) |
DOI | 10.11648/j.sjcm.20251403.12 |
Page(s) | 40-45 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Restriction of the Fetal Growth, Risk Factor, Immunodeficiency
Characteristitics of FGR newborn | Immunodeficiency No % | Immunocompetent No % |
---|---|---|
Exclusive breast feeding | 6 | 3 |
24 | 12 | |
Not exclusive breast feeding | 10 | 6 |
40 | 24 | |
Hospitable revenues | 14 | 3 |
56 | 12 | |
Not hospitable revenues | 2 | 6 |
8 | 24 | |
Fall of the umbilical cord <5 days and >10 days | 8 | 3 |
32 | 12 | |
Fall of the umbilical cord between 5 and 10 days | 8 | 6 |
32 | 24 |
Indicators of immunodeficiency | Sensibility (%) (IC 95%) | Specificity (%) (IC 95%) | Reason of verisimilitude (+) (IC 95%) | Reason of verisimilitude (-) (IC 95%) |
---|---|---|---|---|
Exclusive breast feeding | 37.5 | 66.7 | 1.126 | 0.937 |
Hospitable revenues | 87.5 | 66.7 | 2.628 | 0.187 |
Fall of the umbilical cord <5 days and >10 days | 50 | 66.7 | 1.502 | 0.749 |
Indicators of immunodeficiency | Area of ROC below the curve | Confidential interval (95%) | |
---|---|---|---|
Limit lower | Superior limit | ||
Exclusive breast feeding | 0.4632 | 0.2146 | 0.7119 |
Hospitable revenues | 0.6618 | 0.4392 | 0.8843 |
Fall of the umbilical cord <5 days and >10 days | 0.4459 | 0.1895 | 0.6899 |
TNF- α | Factor of Tumorous Necrosis Alpha |
IL-6 | Interleuquina |
DNA | Deoxyribonucleic Acid |
Th | Owner of Answer |
[1] | Melamed N, Baschat A, Yinon Y, et al. Iniciativa de la FIGO (Federación Internacional de Ginecología y Obstetricia) sobre crecimiento fetal: recomendaciones prácticas para la detección, el diagnóstico y el tratamiento de la restricción del crecimiento fetal. Int J Gynaecol Obstet 2021; 152 (Supl. 1): 3-57. |
[2] | Lees CC, Stampalija T, Baschat A, et al. Guías de práctica de la ISUOG: diagnóstico y manejo del feto pequeño para la edad gestacional y restricción del crecimiento fetal. Ultrasound Obstet Gynecol 2020; 56(2): 298-312. |
[3] | Kesavan K, Devaskar SU. Intrauterine growth restriction: postnatal monitoring and outcomes. Pediatr Clin North Am. 2019; 66(2): 403–23. |
[4] | Ministerio de Salud Pública. Dirección Nacional de Estadísticas. Registro de morbilidad continúa, Servicios cerrados de Neonatología. La Habana: Oficina Nacional de Estadísticas del MINSAP; 2021. |
[5] | Turner S, Williams M. Customized growth charts: rationale, validation and clinical benefits. Am J Obstet Gynecol. 2018; 218(2 Suppl): S609–S618. |
[6] | Lewis DB, Tu W. The physiologic immunodeficiency of immaturity. En: Stiehm RE, Ochs HD, Winkelstein JA. Immunologic disorders in infants and children. Philadelphia: Elsevier Saunders, 2004. p. 687-760. |
[7] | Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles CH et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front. Immunol. 2014; 5: 162. |
[8] | Laboratorios Saval. Lactancia materna refuerza inmunidad de neonatos. Chile: Laboratorios; 2021 [20/11/2021]. |
[9] | Andegiorgish AK, Andemariam M, Temesghen S, Ogbai L, Ogbe Z, Zeng L. Neonatal mortality and associated factors in the specialized neonatal care unit Asmara, Eritrea. BMC Public Health. 2020; 20(1): 10. |
[10] | Jiménez Acosta SM. Alimentación y nutrición en edades pediátricas durante la COVID- 19. Rev Cubana Pediatr. 2020 [acceso 20/11/2021]; 92(1): 15. |
[11] | Rodríguez Avilés DA, Barrera Rivera MK, Tibanquiza Arreaga LP, Montenegro Villavicencio AF. Beneficios inmunológicos de la leche materna. RECIAMUC. 2020; 4(1); 93-104. |
[12] | Tamayo-Velázquez O, Gómez-Tejeda J, Dieguez-Guach R, Iparraguirre-Tamayo A, PérezAbreu M. Intervención educativa sobre los beneficios inmunológicos de la lactancia materna para los lactantes. Rev Cubana de Medicina General Integral. 2022 [citado 11/09/2023]; 38(2). |
[13] | Quezada L, Leon C C, Fernandez S, Nicolau E. Celula Madre: una revolución en la medicina regenerativa. MediSan. 2017; 21(5): 574-81. 2017 [citado 09/02/21]. |
[14] | Martínez-Murillo CI. El banco de células madre hematopoyéticas de cordón umbilical para trasplante. GacMéd Méx.; 139 (Supl 3): S93-S95. [citado 09/02/21]. |
[15] | Gluckman E. History of cord blood trasplantation. Bone Marrow Trasplant.; 44(10): 621-6. PMID: 19802032. [citado 09/02/21]. |
[16] | Huwyler C, Lin SY, Liang J. Primary Immunodeficiency and Rhinosinusitis. Immunol Allergy Clin North Am. 2020; 40: 233-49. Disponible en: |
[17] | Bohy M, Poowuttikul P, Secord E. Humoral Immune Deficiencies of Childhood. Immunol Allergy Clin North Am. 2021; 41: 527-33. Disponible en: |
[18] | Torre P, Salas M, Silva CI. Desafíos para la promoción de la salud: el caso del mercado de las fórmulas infantiles en México. Glob Health Promot. 2020; 27(2): 175–83. |
[19] | Jablonska J, et al. The impact of intrauterine growth restriction on the development of neonatal immune system. Front Immunol. 2022; 13: 957781. |
[20] | Li W, et al. Gut microbiota dysbiosis contributes to impaired intestinal immune development in intrauterine growth restriction piglets. Front Immunol. 2021; 12: 765432. |
[21] | Wu Y, et al. Maternal gut microbiota and its metabolites in offspring health: A review. Aging Dis. 2022; 13(3): 901-918. |
APA Style
Lopez, A. R., Moreno, V. J. H. (2025). Prediction of the Immunodeficiencies in the Restriction of the Fetal Growth. Science Journal of Clinical Medicine, 14(3), 40-45. https://doi.org/10.11648/j.sjcm.20251403.12
ACS Style
Lopez, A. R.; Moreno, V. J. H. Prediction of the Immunodeficiencies in the Restriction of the Fetal Growth. Sci. J. Clin. Med. 2025, 14(3), 40-45. doi: 10.11648/j.sjcm.20251403.12
AMA Style
Lopez AR, Moreno VJH. Prediction of the Immunodeficiencies in the Restriction of the Fetal Growth. Sci J Clin Med. 2025;14(3):40-45. doi: 10.11648/j.sjcm.20251403.12
@article{10.11648/j.sjcm.20251403.12, author = {Adrian Ruiz Lopez and Vicente Jose Hernandez Moreno}, title = {Prediction of the Immunodeficiencies in the Restriction of the Fetal Growth }, journal = {Science Journal of Clinical Medicine}, volume = {14}, number = {3}, pages = {40-45}, doi = {10.11648/j.sjcm.20251403.12}, url = {https://doi.org/10.11648/j.sjcm.20251403.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjcm.20251403.12}, abstract = {Introduction: Birth weight has historically been used as an indicator to assess fetal growth, and newborns below the 10th percentile for a given gestational age have generally been associated with poor outcomes. Current knowledge about the functional capacity of the immune system in the first weeks of life highlights the importance of infections as one of the most important causes of morbidity and mortality in newborns. Objective: To identify risk factors for the onset of immunodeficiency in births with restriction of the fetal growth at the Mariana Grajales Gynecological-Obstetric Hospital in the municipality of Santa Clara, Villa Clara province, from January 2016 to December 2023. Material and Methods: A descriptive, cross-sectional, and retrospective study was carried out in births with restriction of the fetal growth at the Gynecological-Obstetric Hospital of the municipality of Santa Clara, Villa Clara province, from January 2016 to December 2023. The universe was made up of 44 patients. Results: The main risk factor was a history of admission, which represented 56% of the total, followed by not breastfeeding, which in turn represented 40% of the total cases analyzed. Conclusions: It is important to understand the risk factors for the development of immunodeficiency, as well as the warning signs, in order to understand the mechanism of its onset and prevent conditions from leading to the underlying cause.}, year = {2025} }
TY - JOUR T1 - Prediction of the Immunodeficiencies in the Restriction of the Fetal Growth AU - Adrian Ruiz Lopez AU - Vicente Jose Hernandez Moreno Y1 - 2025/08/07 PY - 2025 N1 - https://doi.org/10.11648/j.sjcm.20251403.12 DO - 10.11648/j.sjcm.20251403.12 T2 - Science Journal of Clinical Medicine JF - Science Journal of Clinical Medicine JO - Science Journal of Clinical Medicine SP - 40 EP - 45 PB - Science Publishing Group SN - 2327-2732 UR - https://doi.org/10.11648/j.sjcm.20251403.12 AB - Introduction: Birth weight has historically been used as an indicator to assess fetal growth, and newborns below the 10th percentile for a given gestational age have generally been associated with poor outcomes. Current knowledge about the functional capacity of the immune system in the first weeks of life highlights the importance of infections as one of the most important causes of morbidity and mortality in newborns. Objective: To identify risk factors for the onset of immunodeficiency in births with restriction of the fetal growth at the Mariana Grajales Gynecological-Obstetric Hospital in the municipality of Santa Clara, Villa Clara province, from January 2016 to December 2023. Material and Methods: A descriptive, cross-sectional, and retrospective study was carried out in births with restriction of the fetal growth at the Gynecological-Obstetric Hospital of the municipality of Santa Clara, Villa Clara province, from January 2016 to December 2023. The universe was made up of 44 patients. Results: The main risk factor was a history of admission, which represented 56% of the total, followed by not breastfeeding, which in turn represented 40% of the total cases analyzed. Conclusions: It is important to understand the risk factors for the development of immunodeficiency, as well as the warning signs, in order to understand the mechanism of its onset and prevent conditions from leading to the underlying cause. VL - 14 IS - 3 ER -